SELLAS Life Sciences Group, Inc. — Director's Dealing 2021

Dec 3, 2021

SEC Form 4/A — Form 4/A

Issuer: SELLAS Life Sciences Group, Inc. (SLS)
CIK: 0001390478
Period of Report: 2021-03-04

Reporting Person: Burns John Thomas (VP, Finance & Corp Controller)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17875	Direct

Footnotes

F1: This amended Form 4/A is being filed to correct a mathematical error in Column 5 of the original Form 4 filed on March 8, 2021 regarding the amount of securities beneficially owned by the Reporting Person following the transaction.